Rocket Pharmaceuticals (RCKT) Debt Ratio (2014 - 2021)
Rocket Pharmaceuticals (RCKT) posted Debt Ratio of 0.46 for Q4 2014.
Powered by 
Analysis
Rocket Pharmaceuticals (RCKT) Debt Ratio (2014 - 2021) Analysis & Trends
Rocket Pharmaceuticals has reported Debt Ratio for 1 years, with the latest figure at 0.46 in Q4 2014.
- Quarterly Debt Ratio changed N/A year-over-year to 0.46 in Q4 2014, while the trailing twelve-month figure through Dec 2014 was 0.46 (changed N/A YoY) and the FY2014 annual result came in at 0.46, changed N/A from the prior year.
- Debt Ratio was little changed at 0.46 in Q4 2014 per RCKT's latest filing.
- Over five years, Debt Ratio peaked at 0.46 in Q4 2014 and troughed at 0.46 in Q4 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 0.05 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 0.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.47 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 0.26 |
| 10 | Rocket Pharmaceuticals | 437.27 Mn | 437.27 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | 3.66 |
| Mar 31, 2021 | 7.69 |
| Dec 31, 2020 | 2.78 |
| Sep 30, 2020 | 0.85 |
| Dec 31, 2014 | 1.02 |